The Compounding Pharmacy of America Recalls Recalls by year
A bar chart of the number of recalls naming this company by year.
Recalls by year
Year Recalls 2015 99 2018 1
Download CSV FDA Recall
Terminated
Historical record Class II
5-Methyl Tetrahydrofolate (5-MTHF) 1 mg/ml Injectable, Sterile-Multi-Dose Vial, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-50/PGE 1 0.14/0.08 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-50 8.8 mg/0.29 mg/2.9 mcg Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-106/PGE 2 0.1/0.14 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-105 (30 mg/1 mg/10 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix T-102 (17.65 mg/0.59 mg/10 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST9A (30 MG/2 MG/80 MCG) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST4/PGE 2/LIDO 2 0.1/0.05/0.05 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST4 (3 mg/1.5 mg/300 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST3/PGE 2/LIDO 2 0.06/0.2/0.02 Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix ST2/LIDO2/PGE2 0.2/0.1/0.04, Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
FDA Recall
Terminated
Historical record Class II
Tri-Mix MEDIUM (15 mg/0.5 mg/5 mcg) Injectable, The Compounding Pharmacy of America, Knoxville, TN by The Compounding Pharmacy of America
Reason
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility Published
September 23, 2015 Distribution
Nationwide
View recall →
This page lists recalls that name The Compounding Pharmacy of America as the recalling firm in the official source notice. It is
not a safety rating, ranking, or statement that the company acted negligently.
Read the full medical disclaimer .
